학술논문
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques
Document Type
article
Author
Laura Solforosi; Lea M. M. Costes; Jeroen T. B. M. Tolboom; Katherine McMahan; Tochi Anioke; David Hope; Tetyana Murdza; Michaela Sciacca; Emily Bouffard; Julia Barrett; Cindy Wu; Nicole Hachmann; Jessica Miller; Jingyou Yu; Xuan He; Catherine Jacob-Dolan; Sietske K. Rosendahl Huber; Liesbeth Dekking; Ronnie Chamanza; Ying Choi; Karin Feddes-de Boer; Dan H. Barouch; Hanneke Schuitemaker; Roland C. Zahn; Frank Wegmann
Source
Nature Communications, Vol 14, Iss 1, Pp 1-14 (2023)
Subject
Language
English
ISSN
2041-1723
Abstract
Variant booster vaccines are a strategy to improve protection against SARS-CoV-2. Here, the authors find that both Wuhan-Hu-1-based Ad26.COV2.S or an Omicron-adapted booster vaccine provide robust immune responses and protection against Omicron in NHP.